2565
We report the case of a 14-year-old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA).
 a 14-year-old female with acute promyelocytic leukemia: Subject; 14-year-old: Subject.Age; female: Subject.Gender; symptomatic cardiomyopathy: Effect; 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA): Treatment; acute promyelocytic leukemia: Treatment.Disorder; 4 months: Treatment.Time_elapsed; daunomycin: Treatment.Drug; all-trans retinoic acid: Treatment.Drug; daunomycin: Combination.Drug; all-trans retinoic acid: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 14-year-old female with acute promyelocytic leukemia: Subject; 14-year-old: Subject.Age; female: Subject.Gender; symptomatic cardiomyopathy: Effect; 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA): Treatment; acute promyelocytic leukemia: Treatment.Disorder; 4 months: Treatment.Time_elapsed; daunomycin: Treatment.Drug; all-trans retinoic acid: Treatment.Drug; daunomycin: Combination.Drug; all-trans retinoic acid: Combination.Drug